本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Collegium Pharmaceutical, Inc.

22.20
+0.35501.63%
成交量:7.27萬
成交額:161.17萬
市值:7.23億
市盈率:17.48
高:22.40
開:21.84
低:21.84
收:21.84
52周最高:50.79
52周最低:21.65
股本:3,255.56萬
流通股本:3,136.51萬
量比:0.92
換手率:0.23%
股息:- -
股息率:- -
每股收益(TTM):1.27
每股收益(LYR):1.73
淨資產收益率:17.61%
總資產收益率:5.75%
市淨率:2.32
市盈率(LYR):12.83

資料載入中...

2020/03/27

SEC問詢函

CORRESP [Cover] - Correspondence
2020/02/27

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/27

重要事件披露

Current report, items 2.02 and 9.01
2020/02/21

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

重要事件披露

Current report, items 1.01, 2.01, 2.03, 5.02, 7.01, and 9.01
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/11

[補充]招股説明書

Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/02/10

重要事件披露

Current report, items 1.01, 2.03, and 9.01
2020/02/06

重要事件披露

Current report, items 7.01 and 9.01
2020/02/05

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/04

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/04

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/24

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/01/07

重要事件披露

Current report, items 7.01 and 9.01
2019/11/06

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/06

重要事件披露

Current report, items 2.02 and 9.01
2019/11/01

SEC問詢函

[Cover]Correspondence